Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.680
+0.080 (5.00%)
At close: Nov 26, 2025, 4:00 PM EST
1.740
+0.060 (3.57%)
After-hours: Nov 26, 2025, 7:59 PM EST

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $1.51M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $1.51M.

Revenue (ttm)
$1.51M
Revenue Growth
n/a
P/S Ratio
32.29
Revenue / Employee
$65,449
Employees
23
Market Cap
74.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

OTLK News

More News